- Investing Ideas
- Australian Pharmaceuticals & Biotech Breakout Stocks
Australian Pharmaceuticals & Biotech Breakout Stocks
Results
4
Stocks where the price continues to rise after more than a year of consistent gains.
4 companies
Neuren Pharmaceuticals
Market Cap: AU$2.7b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$21.56
7D
23.3%
1Y
22.8%
PYC Therapeutics
Market Cap: AU$2.1b
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$2.13
7D
27.2%
1Y
71.1%
Nyrada
Market Cap: AU$167.9m
A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.
NYR
AU$0.68
7D
22.5%
1Y
126.7%
Vectus Biosystems
Market Cap: AU$9.8m
Engages in the medical research and development activities in Australia.
VBS
AU$0.16
7D
23.1%
1Y
166.7%